Metabolic response to surgery — neuroendocrine, inflammatory and catabolic phases

Definition / Overview

Every surgical insult, from a minor elective procedure to life-threatening trauma, triggers a stereotyped, integrated physiological response designed to preserve perfusion, mobilise fuel substrates, limit infection, and initiate tissue repair. This response is mediated through two overlapping arms:

• Neuroendocrine axis, hypothalamic-pituitary activation, sympathoadrenal discharge, and release of counter-regulatory hormones.
• Inflammatory cascade, local and systemic release of cytokines, complement, eicosanoids, and acute-phase reactants.

Together, these produce a catabolic state characterised by hypermetabolism, hyperglycaemia, protein breakdown, and fluid and electrolyte shifts. The magnitude of the response is proportional to the severity of the operative insult; understanding its phases and mediators is foundational to perioperative decision-making.

The Two Phases of the Metabolic Response

Ebb Phase (Shock Phase)

• Occurs in the first 12-24 hours after injury or major surgery.
• Characterised by decreased cardiac output, reduced oxygen consumption, lowered body temperature, and depressed basal metabolic rate.
• Represents haemodynamic instability and the body's attempt to limit further losses.
• Clinically: patient is shut down, peripherally vasoconstricted, and catecholamine-driven.

Flow Phase (Catabolic / Hypermetabolic Phase)

• Follows successful resuscitation; may persist for days to weeks depending on insult severity.
• Basal metabolic rate rises above predicted values for age, sex, and body size.
• Characterised by hypermetabolism, net protein catabolism, insulin resistance, and hyperglycaemia.
• After elective surgery the flow phase is typically brief and well-controlled; after major trauma or sepsis it is intense and prolonged.

Neuroendocrine Response

Afferent Limb

The hypothalamus integrates signals from multiple sources:

• Somatic and visceral afferent nerves transmitting pain and tissue-damage signals.
• Circulating mediators, cytokines (particularly IL-1, IL-6, TNF-α) crossing or signalling across the blood-brain barrier.
• Baroreceptor and volume-receptor inputs signalling haemodynamic compromise.

Efferent Limb, Key Counter-Regulatory Hormones

ACTH-Cortisol Axis

• Hypothalamic corticotrophin-releasing hormone (CRH) → anterior pituitary ACTH → adrenal cortisol.
• Cortisol amplifies gluconeogenesis in the liver and drives amino acid mobilisation from skeletal muscle to provide gluconeogenic substrate.
• Cortisol also enhances the sensitivity of the vasculature to catecholamines, critical in maintaining haemodynamic stability.

Sympathoadrenal Discharge

• Immediate response; occurs within minutes of injury.
• Adrenaline from the adrenal medulla and noradrenaline from sympathetic terminals produce the classical "fight or flight" effects: tachycardia, hypertension, diaphoresis, mydriasis, and metabolic substrate mobilisation.

Inflammatory Response

Local vs. Systemic Inflammation

• After elective surgery, the inflammatory response is predominantly local, confined to the operative wound.
• After major accidental injury or extensive surgery, a massive release of mediators overwhelms local containment and spills into the systemic circulation → Systemic Inflammatory Response Syndrome (SIRS).

Key Cellular Mediators

Cytokines:

• TNF-α: Early pro-inflammatory signal; promotes leukocyte adhesion, vasodilatation, and activation of the coagulation cascade.
• IL-1: Synergises with TNF-α; stimulates IL-6 release and induces fever.
• IL-6: A major driver of the acute-phase protein response; reduces IGF-1, promoting proteolysis and amino acid release from muscle. Serum IL-6 correlates with operative severity.
• IL-4, IL-10, IL-13: Anti-inflammatory cytokines that predominate later, bringing the response toward resolution.

Other mediators:

• Complement, opsonisation, membrane attack complex, and amplification of the inflammatory response.
• Eicosanoids, prostaglandins (e.g. PGE2) and leukotrienes (e.g. LT4) are pro-inflammatory early; PGE3 and LT5 contribute to resolution.
• Platelet-activating factor (PAF), promotes platelet aggregation and increases vascular permeability.
• DAMPs (Damage-Associated Molecular Patterns), endogenous molecules released from damaged cells (e.g. HMGB1, heat-shock proteins) that activate pattern recognition receptors (PRRs), triggering sterile inflammation comparable in character to a septic response.

Acute-Phase Protein Response

Directed by IL-6 acting on hepatocytes:

• Rising CRP and falling albumin together reflect the severity of the inflammatory response.
• Serum ferritin rises; free iron is sequestered in the liver, limiting bacterial growth.
• Copper and ceruloplasmin rise (unlike iron and zinc, which fall).

Metabolic / Catabolic Consequences

Insulin Resistance and Hyperglycaemia

The central metabolic disturbance of the flow phase:

• Counter-regulatory hormones (catecholamines, cortisol, glucagon) and cytokines collectively block insulin signalling at the receptor and post-receptor level.
• In the fasted postoperative state, even a three-fold rise in endogenous insulin fails to achieve normal peripheral glucose uptake.

• Net effect: $$\text{Blood glucose} \uparrow = \text{Hepatic glucose output} \uparrow \;+\; \text{Peripheral uptake} \downarrow$$

• Stress hyperglycaemia is associated with impaired wound healing, immune dysfunction, and increased infection risk.

• Target glucose in the perioperative period: generally $4-10\,\text{mmol/L}$ (avoid tight control < 4.5 due to hypoglycaemia risk in most surgical patients).

Protein Catabolism

• Cytokines (particularly IL-6) reduce IGF-1, a major stimulus for muscle anabolism.
• Cortisol and catecholamines drive net muscle proteolysis, releasing amino acids:
  • Alanine and glutamine, primary gluconeogenic substrates delivered to the liver.
  • Branched-chain amino acids (BCAAs), oxidised peripherally for energy.
• Urinary nitrogen excretion rises markedly; a major abdominal operation may result in a negative nitrogen balance of 10-15 g/day.
• Prolonged catabolism leads to loss of respiratory muscle mass, impaired immunity (lymphocyte synthesis requires amino acids), and delayed wound healing.

Lipid Mobilisation

• Catecholamines and cortisol activate hormone-sensitive lipase → lipolysis in adipose tissue.
• Free fatty acids (FFAs) are released into the circulation; taken up by liver and peripheral tissues as fuel.
• Liver converts FFAs to ketone bodies (less pronounced than in pure starvation, as insulin levels, even if resistant, suppress ketogenesis partially).
• Growth hormone amplifies lipolysis.

Carbohydrate Metabolism

• Glycogen stores are rapidly depleted via glycogenolysis (catecholamines, glucagon).
• Gluconeogenesis from amino acids, lactate, and glycerol is upregulated, primarily in the liver (cortisol and glucagon act synergistically here).
• The metabolic response to injury becomes relatively insensitive to feeding, unlike starvation, simply providing glucose will not suppress gluconeogenesis.

Key Distinction: Stress vs. Simple Starvation

Fluid and Electrolyte Changes

• ADH and aldosterone drive avid sodium and water retention → postoperative oliguria is expected in the first 24-48 hours and does not necessarily indicate hypovolaemia.
• Potassium is released from catabolised cells and with aldosterone-mediated kaliuresis can result in either hypo- or hyperkalaemia depending on the clinical context.
• Third space losses, tissue oedema from increased capillary permeability (mediated by histamine, bradykinin, and cytokines) can be substantial in major surgery; may reach several litres.
• Trace elements: zinc and iron fall (hepatic sequestration); copper rises; these parallel nitrogen balance changes.

Clinical Significance and Perioperative Management

Nutritional Support Strategy

• Oral/enteral nutrition is preferred and should be reintroduced as early as safely possible; gut mucosal integrity depends on luminal nutrients.
• Enhanced Recovery After Surgery (ERAS) protocols, carbohydrate loading preoperatively, minimising fasting periods, and early enteral feeding blunt the catabolic response and reduce length of stay.
• Protein requirements increase substantially in the postoperative period; typical targets are $1.2-2.0\,\text{g/kg/day}$ in major surgical illness.
• Overfeeding is harmful (increased $\text{CO}_2$ production, hepatic steatosis, hyperglycaemia), caloric targets should be calculated, not estimated liberally.
• Glutamine supplementation has shown benefit in selected high-catabolic patients (burns, major trauma, some GI surgical patients), it is a conditionally essential amino acid during severe stress.

Glycaemic Control

1. Monitor blood glucose at least 2-hourly in ICU / high-dependency patients.
2. Use insulin infusion protocols to target $6-10\,\text{mmol/L}$.
3. Avoid hypoglycaemia, risk of neurological harm; aim is moderate not tight control.

Attenuation of the Stress Response

• Neuraxial anaesthesia (epidural / spinal) partially blocks afferent nociceptive signals, attenuating the neuroendocrine response, particularly effective for lower limb and abdominal operations.
• Multimodal analgesia (NSAIDs, paracetamol, opioid-sparing techniques) reduces pain-driven sympathoadrenal activation.
• Minimally invasive surgery (laparoscopic/robotic) produces a smaller inflammatory footprint compared to open surgery for equivalent procedures.
• ERAS protocols combine these strategies with early mobilisation, reducing the catabolic burden.

Smoking Cessation and Prehabilitation

• Nicotine causes vasoconstriction and impairs oxygen delivery; carbon monoxide shifts the oxygen-dissociation curve leftward. Cessation before surgery (the longer the better) reduces pulmonary and wound complications.
• Prehabilitation, structured cardiopulmonary exercise in the weeks before major surgery improves physiological reserve, reduces postoperative complications, and shortens hospital stay.

Complications and Special Considerations

SIRS, Sepsis, and Multiple Organ Failure

• An uncontrolled or persistent systemic inflammatory response may progress from SIRS → sepsis → severe sepsis → multiple organ dysfunction syndrome (MODS).
• MODS represents the end-organ consequences of sustained cytokine and mediator excess, impaired oxygen utilisation despite adequate delivery.

Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS)

• A recognised clinical trajectory in critically ill surgical patients who survive the initial insult but fail to recover.
• Characterised by ongoing inflammation, progressive immunosuppression, and unrelenting catabolism.
• Results in prolonged ICU stay, poor functional recovery, and high late mortality.

Adrenal Insufficiency

• Rarely, patients on long-term corticosteroids or with pituitary/adrenal pathology fail to mount an adequate cortisol response.
• Critical illness-related corticosteroid insufficiency (CIRCI), suspect in vasopressor-dependent shock not responding to fluids; consider hydrocortisone supplementation.

Cancer Cachexia

• A chronic, low-grade inflammatory state superimposed on malnutrition.
• Elevated TNF-α, IL-6, and other cytokines drive ongoing muscle wasting and anorexia that is not reversed by nutritional supplementation alone, the inflammatory driver must also be addressed.

GSSE Viva / MCQ High-Yield Points

• The ebb phase is early and hypometabolic; the flow phase is delayed and hypermetabolic.
• Cortisol, glucagon, and catecholamines are the three primary counter-regulatory hormones, know their individual metabolic effects.
• IL-6 is the principal driver of the acute-phase protein response and reduces IGF-1, promoting muscle proteolysis.
• Albumin falls (negative acute-phase reactant); CRP rises, both are useful clinical markers.
• The catabolic response is relatively insensitive to feeding, unlike starvation, gluconeogenesis continues even when glucose is provided.
• Neuraxial anaesthesia blunts the neuroendocrine response more effectively than systemic opioids alone.
• ERAS reduces surgical stress response, insulin resistance, and postoperative catabolism through a bundle of evidence-based interventions.
• Glucose target in surgical ICU: $\approx 6-10\,\text{mmol/L}$; avoid tight control below $4.5\,\text{mmol/L}$.

Sources

• RACS position statements & curriculum (Royal Australasian College of Surgeons)
• ATLS (Advanced Trauma Life Support)